State of the Discovery Nation 2019

New insights into the UK's growing medicines discovery industry

Medicines Discovery Catapult

The 2019 edition of the State of the Discovery Nation report by the Medicines Discovery Catapult and the BIA reveals a thriving service and supply sector for the UK in addition to its R&D biotech’s. It also highlights two breakthrough technologies set to influence the future of medicines discovery and maintain the UK’s global competitiveness.

Key insights from the report reveal:

  • 300 companies are focussed on discovering potential new medicines; 70% are working in the areas of cancer, anti-infectives and the central nervous system.
  • 1,200 companies provide vital services and supplies.
  • Despite their size, SMEs are a critical source of innovation for new medicines; 60% have fewer than 5 staff and 80% have fewer than 20 people within the company.
  • The UK now has an opportunity to apply new cutting-edge science and technology to make medicines discovery more productive especially in the areas of Artificial Intelligence (AI) and Complex Cell Models (CCMs).

Read the report

Want a brief overview of the findings? Download the Key Insights report >

Read the special report on Artificial Intelligence in Drug Discovery >

Read the press release about the launch of State of the Discovery Nation 2019 >